Arena Pharmaceuticals, Inc.
(NASDAQ : ARNA)

( )
ARNA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Loading ARNA News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-1.00%163.061.3%$781.81m
GILDGilead Sciences, Inc.
0.24%67.261.0%$568.09m
CELGCelgene Corporation
-0.27%124.091.1%$481.61m
BIIBBiogen Inc.
-2.04%268.531.3%$446.03m
REGNRegeneron Pharmaceuticals, Inc.
3.03%394.142.1%$385.16m
INCYIncyte Corporation
-0.14%139.284.3%$353.74m
VRTXVertex Pharmaceuticals Incorporated
20.45%108.012.0%$218.70m
KITEKite Pharma, Inc.
-0.13%78.5117.5%$216.08m
ALXNAlexion Pharmaceuticals, Inc.
1.85%120.721.6%$208.60m
TSROTESARO, Inc.
-1.95%151.8815.6%$193.33m
ILMNIllumina, Inc.
1.08%172.663.4%$164.78m
ESPREsperion Therapeutics, Inc.
-2.44%34.7917.7%$146.82m
CLVSClovis Oncology, Inc.
-3.98%64.3917.2%$135.52m
AUPHAurinia Pharmaceuticals Inc.
1.96%7.308.0%$134.79m
EXELExelixis, Inc.
-0.71%21.135.7%$98.01m

Company Profile

Arena Pharmaceuticals, Inc. is a biopharmaceutical company engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers a range of drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.